Related Experiment Video

Updated: Aug 24, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Treatment of acute hepatitis C

Wiesław Kryczka1, Dorota Zarebska-Michaluk

  • 1Department of Infectious Diseases, General Provincial Hospital, Kielce, Poland. wkryczka@mp.pl

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|May 26, 2004
PubMed

Insights

Antiviral therapy for acute hepatitis C (AHC) shows promise, particularly for patients with early anti-HCV seroconversion. Treatment led to higher sustained response rates compared to natural outcomes in untreated individuals.

Area of Science:

  • Hepatology
  • Virology
  • Clinical Medicine

Background:

  • Acute hepatitis C (AHC) is a significant public health concern.
  • Understanding the natural course and treatment outcomes of AHC is crucial for effective patient management.

Purpose of the Study:

  • To evaluate the efficacy of antiviral treatment in patients with AHC.
  • To compare the outcomes of treated AHC patients with those of untreated patients.

Main Methods:

  • A cohort of 10 treated AHC patients received interferon monotherapy or combined interferon and ribavirin therapy.
  • A control group of 50 untreated AHC patients was compared.
  • Treatment response was assessed by biochemical (ALT levels) and virological (HCV-RNA) markers.

Main Results:

  • Nine out of ten treated patients achieved rapid normalization of ALT levels.
  • Sustained response was observed in 70% of treated patients versus 44% of untreated patients (p=n.s.).
  • A significant beneficial effect was noted in patients with early anti-HCV seroconversion (7/9 treated vs. 8/29 untreated, p=0.021).

Conclusions:

  • Antiviral therapy appears effective for AHC and should be considered, especially in early seroconversion cases.
  • Ribavirin may benefit patients unresponsive to interferon monotherapy.
  • Early intervention with antiviral treatment can improve sustained response rates in AHC.
Abstract

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...